Medacta Group SA

Common Name
Medacta Group
Country
Switzerland
Sector
Healthcare
Industry
Medical Devices
Employees
2,041
Ticker
MOVE
Exchange
SIX SWISS EXCHANGE
Description
Medacta Group SA is a global leader specializing in the design, production, and distribution of orthopedic medical devices. Its core operations focus on joint replacement implants, including hip, knee...
GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Medacta Group's GHG Emissions Data Preview

In 2024, Medacta Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Medacta Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Medacta Group’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Medacta Group’s data sources below and access millions more through our Disclosure Search.

a. Medacta Group's Sustainability Report 2024
a. Medacta Group's Sustainability Report 2024

Insights into Medacta Group's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Medacta Group amounted to 1,916 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Medacta Group increased by 31.41%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Medacta Group's Scope 1 Emissions Over Time

2023202403507001.05 k1.4 ktCO2e+37%
  • Total Scope 1
  • Year-over-Year Change

What are Medacta Group's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Medacta Group were 1,296 metric tons of CO₂ equivalent (tCO₂e). a

Compared to the previous year (2023), Medacta Group's Scope 1 emissions increased by 36.56%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are Medacta Group's Scope 2 emissions?

In 2024, Medacta Group reported Scope 2 greenhouse gas (GHG) emissions of 321 tCO₂e using the market-based method and 620 tCO₂e using the location-based method. a

Has Medacta Group reduced its Scope 2 emissions over time?

Compared to the previous year (2023), Medacta Group's Scope 2 emissions (Location-Based) rose by 21.81% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a

What methodology does Medacta Group use for Scope 2 reporting?

In 2024, Medacta Group reported its Scope 2 emissions using the market-based method and using the location-based method. a

Medacta Group's Scope 2 Emissions Over Time

202320240200400600800tCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Medacta Group’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Medacta Group reported Scope 1 greenhouse gas (GHG) emissions of 1,296 tCO₂e and total revenues of USD 577 millions. This translates into an emissions intensity of 2.25 tCO₂e per millions USD. a

Medacta Group's Scope 1 Emissions Intensity Compared to Peers

101002,00020,000200,000Scope 1 Emissions (tCO2e)202001,0005,00050,000Revenues (Millions of USD)MEInteger HoldingsYear: 2023Scope 1: 7,066 tCO2eRevenue: $M 1,597Scope 1 Intensity: 4.43 tCO2e/$MSnibeYear: 2023Scope 1: 210 tCO2eRevenue: $M 553Scope 1 Intensity: 0.38 tCO2e/$MStratecYear: 2024Scope 1: 814 tCO2eRevenue: $M 268Scope 1 Intensity: 3.04 tCO2e/$MMicroport ScientificYear: 2023Scope 1: 3,168 tCO2eRevenue: $M 7,404Scope 1 Intensity: 0.43 tCO2e/$MSectraYear: 2024Scope 1: 148 tCO2eRevenue: $M 269Scope 1 Intensity: 0.55 tCO2e/$MYpsomed HoldingYear: 2024Scope 1: 2,198 tCO2eRevenue: $M 608Scope 1 Intensity: 3.61 tCO2e/$MInspire Medical SystemsYear: 2023Scope 1: 51 tCO2eRevenue: $M 625Scope 1 Intensity: 0.08 tCO2e/$MMedartis HoldingYear: 2024Scope 1: 877 tCO2eRevenue: $M 248Scope 1 Intensity: 3.53 tCO2e/$MSonova HoldingYear: 2025Scope 1: 10,178 tCO2eRevenue: $M 4,370Scope 1 Intensity: 2.33 tCO2e/$MElektaYear: 2024Scope 1: 6,141 tCO2eRevenue: $M 1,643Scope 1 Intensity: 3.74 tCO2e/$MNolatoYear: 2023Scope 1: 1,585 tCO2eRevenue: $M 946Scope 1 Intensity: 1.68 tCO2e/$MAmbuYear: 2024Scope 1: 3,369 tCO2eRevenue: $M 805Scope 1 Intensity: 4.18 tCO2e/$MGlaukosYear: 2024Scope 1: 523 tCO2eRevenue: $M 383Scope 1 Intensity: 1.36 tCO2e/$MMMMicroport Cardioflow MedtechYear: 2023Scope 1: 268 tCO2eRevenue: $M 52Scope 1 Intensity: 5.18 tCO2e/$MVenus Medtech HangzhouYear: 2024Scope 1: 31 tCO2eRevenue: $M 71Scope 1 Intensity: 0.44 tCO2e/$MDraegerwerk AG & CoYear: 2023Scope 1: 31,865 tCO2eRevenue: $M 3,734Scope 1 Intensity: 8.53 tCO2e/$MLivaNovaYear: 2024Scope 1: 14,173 tCO2eRevenue: $M 1,253Scope 1 Intensity: 11.31 tCO2e/$MCochlearYear: 2025Scope 1: 951 tCO2eRevenue: $M 1,542Scope 1 Intensity: 0.62 tCO2e/$MEEEmbla MedicalYear: 2024Scope 1: 2,290 tCO2eRevenue: $M 5,437Scope 1 Intensity: 0.42 tCO2e/$MMGI TechYear: 2023Scope 1: 18 tCO2eRevenue: $M 409Scope 1 Intensity: 0.04 tCO2e/$MBoston ScientificYear: 2024Scope 1: 87,567 tCO2eRevenue: $M 16,747Scope 1 Intensity: 5.23 tCO2e/$MQuidelOrthoYear: 2023Scope 1: 22,544 tCO2eRevenue: $M 2,998Scope 1 Intensity: 7.52 tCO2e/$MGN Store NordYear: 2024Scope 1: 2,748 tCO2eRevenue: $M 2,506Scope 1 Intensity: 1.10 tCO2e/$MMedacta GroupYear: 2024Scope 1: 1,296 tCO2eRevenue: $M 577Scope 1 Intensity: 2.25 tCO2e/$M

How does Medacta Group's GHG emissions intensity compare to its peers?

In 2024, Medacta Group reported a Scope 1 emissions intensity of 2.25 tCO₂e per millions USD. Compared to the peer group median of 2.33 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Medacta Group rank on GHG emissions intensity within its industry?

In 2024, Medacta Group ranked 12 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Medacta Group is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Medacta Group's GHG Emissions Dataset?
Sign Up

Explore Peer Companies

Sonova Holding AG

Healthcare
Medical Devices
Switzerland

Medartis Holding AG

Healthcare
Medical Devices
Switzerland

Ambu A/S

Healthcare
Medical Devices
Denmark

MGI Tech Co Ltd

Healthcare
Medical Devices
China (Mainland)

Embla Medical hf

Healthcare
Medical Devices
Iceland

Cochlear Ltd

Healthcare
Medical Devices
Australia